CD39-ASO

N/A

Report date: 2024/09/13 14:04:24
NME

Base Information

Drug NameCD39-ASO
Drug Alias NameCD39-ASO
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAnti-Ectonucleoside triphosphate diphosphohydrolase 1
TargetsEctonucleoside triphosphate diphosphohydrolase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSecarna Pharmaceuticals GmbH & Co KG
China Registration ClassN/A

Develop Information

Active CompaniesSecarna Pharmaceuticals GmbH & Co KG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A